Pontine tegmental cap dysplasia

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:269229OMIM:614688Q04.8
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Pontine tegmental cap dysplasia (PTCD) is an extremely rare congenital hindbrain malformation characterized by a distinctive cap-like protuberance on the dorsal surface of the pons, visible on brain MRI. This neurodevelopmental disorder primarily affects the brainstem and cranial nerves, resulting from abnormal axonal guidance during embryonic development. The condition was first described in 2007 and affects multiple body systems due to cranial nerve dysfunction. Key clinical features include multiple cranial nerve palsies, which can manifest as hearing loss (sensorineural deafness), facial weakness, swallowing difficulties (dysphagia), and impaired eye movements. Many patients also exhibit ataxia (impaired coordination), cognitive impairment of variable severity, and structural brain anomalies beyond the pontine malformation, including cerebellar hypoplasia and absence or hypoplasia of specific cranial nerves. Additional features may include short stature, scoliosis, and cardiac or dental anomalies. Breathing and feeding difficulties may be prominent in the neonatal period. There is currently no curative treatment for pontine tegmental cap dysplasia. Management is supportive and multidisciplinary, focusing on addressing individual symptoms such as hearing aids or cochlear implants for hearing loss, speech therapy, physical therapy for motor difficulties, and nutritional support for feeding problems. Prognosis varies depending on the severity of brainstem involvement. Fewer than 40 cases have been reported in the medical literature worldwide.

Also known as:

Inheritance

Sporadic

Usually appears on its own, not inherited from a parent

Age of Onset

Neonatal

Begins at or shortly after birth (first 4 weeks)

Orphanet ↗OMIM ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Pontine tegmental cap dysplasia.

View clinical trials →

No actively recruiting trials found for Pontine tegmental cap dysplasia at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Pontine tegmental cap dysplasia community →

No specialists are currently listed for Pontine tegmental cap dysplasia.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Pontine tegmental cap dysplasia.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Pontine tegmental cap dysplasiaForum →

No community posts yet. Be the first to share your experience with Pontine tegmental cap dysplasia.

Start the conversation →

Latest news about Pontine tegmental cap dysplasia

No recent news articles for Pontine tegmental cap dysplasia.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Pontine tegmental cap dysplasia

What is Pontine tegmental cap dysplasia?

Pontine tegmental cap dysplasia (PTCD) is an extremely rare congenital hindbrain malformation characterized by a distinctive cap-like protuberance on the dorsal surface of the pons, visible on brain MRI. This neurodevelopmental disorder primarily affects the brainstem and cranial nerves, resulting from abnormal axonal guidance during embryonic development. The condition was first described in 2007 and affects multiple body systems due to cranial nerve dysfunction. Key clinical features include multiple cranial nerve palsies, which can manifest as hearing loss (sensorineural deafness), facial

How is Pontine tegmental cap dysplasia inherited?

Pontine tegmental cap dysplasia follows a sporadic inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does Pontine tegmental cap dysplasia typically begin?

Typical onset of Pontine tegmental cap dysplasia is neonatal. Age of onset can vary across affected individuals.